Code of Conduct
Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
Search
Our Expectations
We are committed to exemplary ethical and professional conduct both within the company and from our suppliers.
Health, Safety & Environment
Suppliers aim to ensure a safe and healthy working environment and to act in an ecological and sustainable manner.
Ethics and Compliance
Consistent with the Core of our Leitbild and Code of Conduct, we act with integrity and are committed to conducting business in a lawful and ethical manner.
Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
Boehringer Ingelheim Code of Conduct 2024
Data Protection Notice Members Healthcare Professions
Data Protection Notice Members Healthcare Professions
Pride Month: Colleagues from the LGBTQIA+ community and allies share their views on our culture of respect
In June, as the world celebrates Pride Month, we asked three of our colleagues to share their thoughts on the significance of respect at our company.
Data Protection Notice for Members of Healthcare Professions in Animal Health
Data Protection Notice for Members of Healthcare Professions in Animal Health
The Oscars of Science
Revolutionary advances in physics and chemistry used at Boehringer Ingelheim
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
Important Documents
Important Documents for Suppliers
Terms of Use
Terms of Use
Living and Working in Times of War - Employees from Ukraine Report
Living and Working in Times of War - Employees from Ukraine Report
The domino effect of cardiovascular, renal and metabolic conditions
The domino effect of cardiovascular, renal and metabolic conditions
Improving the current state of schizophrenia care
A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition
Boehringer Ingelheim Office Hours
Boehringer Ingelheim Office Hours
Purchasing
Purchasing at Boehringer Ingelheim
More Potential: Overview
Society continues to face challenges ranging from health to education, work prospects, living conditions, inequalities and poverty, often impacting vulnerable communities the most.
Schizophrenia in real life
Through these real-life stories, discover the eye-opening reality of life with schizophrenia.
EFPIA Transparency Reports
EFPIA Transparency Reports
Clinical Studies
Clinical Studies
Research Institute of Molecular Pathology IMP
Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the Research Institute of Molecular Pathology (IMP) is a leading institute for biomedical researchin Vienna, Austria.
Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons
Data Privacy Notice for Customers, Partners, Visitors, Distributors and interested Persons
The Research Process
The Research Process